About Research at PCC

From discovery to application: prostate cancer research is forging a new frontier of hope
 

Prostate cancer is the most common cancer in Canadian men, with one in seven facing a diagnosis during his lifetime. Over the course of the past 20 years, however, deaths from prostate cancer have decreased by approximately 40 percent. This reduction is attributable to a number of advances in the areas of early detection, treatment, and equally as important, public education, awareness, and support of those living with the disease. Each of these advances has been made possible thanks to our most effective method of producing new, evidence-based understanding: research.

In much the same way as research has been the driving force behind progress made to date, it will continue to be the engine of new knowledge generation. This means developing ways of detecting the disease earlier and with more accuracy; personalizing treatments and reducing their side-effects; devising health systems and survivorship support programs that make care as accessible, holistic, and valuable as possible; and saving more lives.

To this end, Prostate Cancer Canada is helping lead the charge by investing heavily in Canada’s most promising studies and minds in the field of prostate cancer research. We ensure the most effective and efficient allocation of the funds we bring in through various means by employing a rigorous peer review process that seeks the guidance of experts from around the world to determine which projects to invest in to further reduce the burden of the disease.

In addition, we place a strong emphasis on supporting men and their circles of care throughout the prostate cancer journey. Given the high incidence of the disease and increasing survival rates, providing equal access to high quality educational and support resources and services is an imperative pillar of our mandate.
Without the support of generous Canadian individuals and organizations, none of this would be possible. On behalf of the one in seven men and their networks of love and support, we thank you for your support. We’re all in this together.

Donations in action

 



 

 

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive